Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
2001 1
2005 3
2006 2
2007 1
2010 2
2015 2
2016 2
2017 2
2018 1
2020 4
2021 7
2022 10
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators. Wilcox MH, et al. N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Free article. Clinical Trial.
TB and COVID-19 coinfection.
Kozińska M, Podlasin R, Ropelewska-Łącka K, Wojtycha-Kwaśnica B, Bajera-Mitschein I, Augustynowicz-Kopeć E. Kozińska M, et al. Among authors: podlasin r. Int J Tuberc Lung Dis. 2021 Sep 1;25(9):776-777. doi: 10.5588/ijtld.21.0358. Int J Tuberc Lung Dis. 2021. PMID: 34802504 No abstract available.
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
Fallerini C, Picchiotti N, Baldassarri M, Zguro K, Daga S, Fava F, Benetti E, Amitrano S, Bruttini M, Palmieri M, Croci S, Lista M, Beligni G, Valentino F, Meloni I, Tanfoni M, Minnai F, Colombo F, Cabri E, Fratelli M, Gabbi C, Mantovani S, Frullanti E, Gori M, Crawley FP, Butler-Laporte G, Richards B, Zeberg H, Lipcsey M, Hultström M, Ludwig KU, Schulte EC, Pairo-Castineira E, Baillie JK, Schmidt A, Frithiof R; WES/WGS Working Group Within the HGI; GenOMICC Consortium; GEN-COVID Multicenter Study; Mari F, Renieri A, Furini S. Fallerini C, et al. Hum Genet. 2022 Jan;141(1):147-173. doi: 10.1007/s00439-021-02397-7. Epub 2021 Dec 10. Hum Genet. 2022. PMID: 34889978 Free PMC article.
Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy.
Jaroszewicz J, Kowalska J, Pawłowska M, Rogalska M, Zarębska-Michaluk D, Rorat M, Lorenc B, Czupryna P, Sikorska K, Piekarska A, Dworzańska A, Zaleska I, Mazur W, Kozielewicz D, Kłos K, Podlasin R, Angielski G, Oczko-Grzesik B, Figlerowicz M, Szetela B, Bolewska B, Frańczak-Chmura P, Flisiak R, Tomasiewicz K. Jaroszewicz J, et al. Among authors: podlasin r. Cancers (Basel). 2022 Sep 28;14(19):4720. doi: 10.3390/cancers14194720. Cancers (Basel). 2022. PMID: 36230641 Free PMC article.
The Course of COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases.
Rorat M, Zarębska-Michaluk D, Kowalska J, Kujawa K, Rogalska M, Kozielewicz D, Lorenc B, Sikorska K, Czupryna P, Bolewska B, Maciukajć J, Piekoś T, Podlasin R, Dworzańska A, Mazur W, Brzdęk M, Szymanek-Pasternak A, Flisiak R. Rorat M, et al. Among authors: podlasin r. J Clin Med. 2022 Dec 10;11(24):7342. doi: 10.3390/jcm11247342. J Clin Med. 2022. PMID: 36555957 Free PMC article.
Healthcare delivery for HIV-positive people with tuberculosis in Europe.
Bentzon AK, Panteleev A, Mitsura V, Borodulina E, Skrahina A, Denisova E, Tetradov S, Podlasin R, Riekstina V, Kancauskiene Z, Paduto D, Mocroft A, Trofimova T, Miller R, Post F, Grezesczuk A, Lundgren JD, Inglot M, Podlekareva D, Bolokadze N, Kirk O; TB:HIV Study Group. Bentzon AK, et al. Among authors: podlasin r. HIV Med. 2021 Apr;22(4):283-293. doi: 10.1111/hiv.13016. Epub 2020 Nov 20. HIV Med. 2021. PMID: 33215809 Free PMC article.
Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance.
Flisiak R, Zarębska-Michaluk D, Rogalska M, Kryńska JA, Kowalska J, Dutkiewicz E, Dobrowolska K, Jaroszewicz J, Moniuszko-Malinowska A, Rorat M, Podlasin R, Tronina O, Rzymski P. Flisiak R, et al. Among authors: podlasin r. Pharmacol Rep. 2022 Dec;74(6):1279-1285. doi: 10.1007/s43440-022-00408-6. Epub 2022 Aug 24. Pharmacol Rep. 2022. PMID: 36001284 Free PMC article.
Hospital Admission Factors Independently Affecting the Risk of Mortality of COVID-19 Patients.
Paciorek M, Bieńkowski C, Kowalska JD, Skrzat-Klapaczyńska A, Bednarska A, Krogulec D, Cholewińska G, Kowalski J, Podlasin R, Ropelewska-Łącka K, Wasilewski P, Boros PW, Martusiewicz-Boros MM, Pulik P, Pihowicz A, Horban A. Paciorek M, et al. Among authors: podlasin r. J Clin Med. 2023 Sep 28;12(19):6264. doi: 10.3390/jcm12196264. J Clin Med. 2023. PMID: 37834907 Free PMC article.
36 results